Search Results - "Bressler, L.R."

Predictors of duloxetine response in patients with oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601 by Smith, E.M.L., Pang, H., Ye, C., Cirrincione, C., Fleishman, S., Paskett, E.D., Ahles, T., Bressler, L.R., Le‐Lindqwister, N., Fadul, C.E., Loprinzi, C., Shapiro, C.L.

“…Duloxetine is an effective treatment for oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN). However, predictors of duloxetine…”
Get full text

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601 by Smith, E.M.L, Pang, H, Ye, C, Cirrincione, C, Fleishman, S, Paskett, E.D, Ahles, T, Bressler, L.R, Le-Lindqwister, N, Fadul, C.E, Loprinzi, C, Shapiro, C.L

“…Duloxetine is an effective treatment for oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN). However, predictors of duloxetine…”
Get full text